Structural design of the anti-TNFα therapeutic NANOBODY® compound, ozoralizumab, to support its potent and sustained clinical efficacy.
作者信息
Mima Masashi, Mishima-Tsumagari Chiemi, Nakano Koichiro, Morimoto Mai, Ogata Hitoshi, Sakata Mayumi, Iwaoka Ryo, Iwata Katsuya, Hachiuma Kenji, Iwamoto Kunihiko, Fujii Yasuyuki, Kurokawa Tomofumi
机构信息
Taisho Pharmaceutical Co., Ltd., 1-403, Yoshino-cho, Kita-ku, Saitama, 331-9530, Japan.
Taisho Pharmaceutical Co., Ltd., 1-403, Yoshino-cho, Kita-ku, Saitama, 331-9530, Japan.
出版信息
Biochem Biophys Res Commun. 2024 Nov 19;734:150454. doi: 10.1016/j.bbrc.2024.150454. Epub 2024 Jul 26.
PMID:39083975
Abstract
摘要
Zotero 插件